Synergistic anti-inflammatory effects of nobiletin and sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cells

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 9, 2012, Pages 2157-2164

  Guo, Shanshan ^a,b   Qiu, Peiju ^b   Xu, Guang ^b   Wu, Xian ^b   Dong, Ping ^b   Yang, Guanpin ^a   Zheng, Jinkai ^b   McClements, David Julian ^b   Xiao, Hang ^b  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

COX 2; Inflammation; INOS; Nitric oxide; Nobiletin; Sulforaphane

Indexed keywords

COX-2; INFLAMMATION; INOS; NOBILETIN; SULFORAPHANE;

NITRIC OXIDE; POLYMERASE CHAIN REACTION; PORPHYRINS;

PATHOLOGY;

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; FLAVONE DERIVATIVE; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NOBILETIN; SULFORAFAN; THIOCYANIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYCLOOXYGENASE 2 INHIBITORS; DRUG SYNERGISM; FLAVONES; GENE EXPRESSION; HEME OXYGENASE-1; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; THIOCYANATES;

EID: 84859739071     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf300129t     Document Type: Article

References (30)

1. Schetter, A. J.; Heegaard, N. H.; Harris, C. C. Inflammation and cancer: Interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010, 31 (1), 37-49.
2. Hibbs, J. B. Jr. Synthesis of nitric oxide from L-arginine: A recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res. Immunol. 1991, 142 (7), 565-569 discussion 596-598.
3. Ohshima, H.; Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994, 305 (2), 253-264. (Pubitemid 24082901)
4. Arroyo, P. L.; Hatch-Pigott, V.; Mower, H. F.; Cooney, R. V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. 1992, 281 (3), 193-202.
5. Miwa, M.; Stuehr, D. J.; Marletta, M. A.; Wishnok, J. S.; Tannenbaum, S. R. Nitrosation of amines by stimulated macrophages. Carcinogenesis 1987, 8 (7), 955-958. (Pubitemid 17122777)
6. Wink, D. A.; Kasprzak, K. S.; Maragos, C. M.; Elespuru, R. K.; Misra, M.; Dunams, T. M.; Cebula, T. A.; Koch, W. H.; Andrews, A. W.; Allen, J. S.; et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991, 254 (5034), 1001-1003. (Pubitemid 21917428)
7. Tsujii, M.; Kawano, S.; DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (7), 3336-3340. (Pubitemid 27157312)
8. Sheng, H.; Shao, J.; Morrow, J. D.; Beauchamp, R. D.; DuBois, R. N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998, 58 (2), 362-366. (Pubitemid 28047080)
9. Liu, X. H.; Kirschenbaum, A.; Yao, S.; Stearns, M. E.; Holland, J. F.; Claffey, K.; Levine, A. C. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastasis 1999, 17 (8), 687-694. (Pubitemid 30450191)
10. Coussens, L. M.; Werb, Z. Inflammation and cancer. Nature 2002, 420 (6917), 860-867. (Pubitemid 36019639)
11. Lin, N.; Sato, T.; Takayama, Y.; Mimaki, Y.; Sashida, Y.; Yano, M.; Ito, A. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem. Pharmacol. 2003, 65 (12), 2065-2071. (Pubitemid 36629589)
12. Yoshimizu, N.; Otani, Y.; Saikawa, Y.; Kubota, T.; Yoshida, M.; Furukawa, T.; Kumai, K.; Kameyama, K.; Fujii, M.; Yano, M.; Sato, T.; Ito, A.; Kitajima, M. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: Antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment. Pharmacol. Ther. 2004, 20 (Suppl. 1), 95-101. (Pubitemid 39120279)
13. Harada, S.; Tominari, T.; Matsumoto, C.; Hirata, M.; Takita, M.; Inada, M.; Miyaura, C. Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFkappaB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency. J. Pharmacol. Sci. 2011, 115 (1), 89-93.
14. Murakami, A.; Nakamura, Y.; Torikai, K.; Tanaka, T.; Koshiba, T.; Koshimizu, K.; Kuwahara, S.; Takahashi, Y.; Ogawa, K.; Yano, M.; Tokuda, H.; Nishino, H.; Mimaki, Y.; Sashida, Y.; Kitanaka, S.; Ohigashi, H. Inhibitory effect of citrus nobiletin on phorbol esterinduced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 2000, 60 (18), 5059-5066.
15. Lin, W.; Wu, R. T.; Wu, T.; Khor, T. O.; Wang, H.; Kong, A. N. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 2008, 76 (8), 967-973.
16. Heiss, E.; Herhaus, C.; Klimo, K.; Bartsch, H.; Gerhauser, C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 2001, 276 (34), 32008-32015.
17. Xiao, H.; Yang, C. S. Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention. Int. J. Cancer 2008, 123 (5), 983-990.
18. Xiao, H.; Yang, C. S.; Li, S.; Jin, H.; Ho, C.-T.; Patel, T. Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis. Mol. Nutr. Food Res. 2009, 53 (3), 398-406.
19. Xiao, H.; Zhang, Q.; Lin, Y.; Reddy, B. S.; Yang, C. S. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int. J. Cancer 2008, 122 (9), 2115-2124. (Pubitemid 351441204)
20. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25 (4), 402-408. (Pubitemid 34164012)
21. Cheung, K. L.; Khor, T. O.; Kong, A. N. Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Pharm. Res. 2009, 26 (1), 224-231.
22. Dinarello, C. A. The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev. 2006, 25 (3), 307-313. (Pubitemid 44922351)
23. Lin, W. W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117 (5), 1175-1183. (Pubitemid 46718402)
24. Chen, X. L.; Kunsch, C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: A new therapeutic approach for the treatment of inflammatory diseases. Curr. Pharm. Des. 2004, 10 (8), 879-891. (Pubitemid 38380066)
25. Li, N.; Alam, J.; Venkatesan, M. I.; Eiguren-Fernandez, A.; Schmitz, D.; Di Stefano, E.; Slaughter, N.; Killeen, E.; Wang, X.; Huang, A.; Wang, M.; Miguel, A. H.; Cho, A.; Sioutas, C.; Nel, A. E. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: Protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J. Immunol. 2004, 173 (5), 3467-3481. (Pubitemid 39142058)
26. Lin, C. C.; Liu, X. M.; Peyton, K.; Wang, H.; Yang, W. C.; Lin, S. J.; Durante, W. Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler., Thromb., Vasc. Biol. 2008, 28 (4), 739-745. (Pubitemid 351651343)
27. Wang, W. W.; Smith, D. L.; Zucker, S. D. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 2004, 40 (2), 424-433. (Pubitemid 39062860)
28. Suh, G. Y.; Jin, Y.; Yi, A. K.; Wang, X. M.; Choi, A. M. CCAAT/ enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2. Am. J. Respir. Cell Mol. Biol. 2006, 35 (2), 220-226. (Pubitemid 44175322)
29. Thorup, C.; Jones, C. L.; Gross, S. S.; Moore, L. C.; Goligorsky, M. S. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am. J. Physiol. 1999, 277 (6 Part 2), F882-F889. (Pubitemid 30046063)
30. Pan, M. H.; Lai, C. S.; Wang, Y. J.; Ho, C.-T. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem. Pharmacol. 2006, 72 (10), 1293-1303. (Pubitemid 44572187)